Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RETA    crawled date : 2021 - 05 - 19    save search
CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
Published: 2021-05-19 (Crawled : 15:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 13.45% H: 9.49% C: 9.11%
CNSP | News | $0.1991 11K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 3.19% C: -1.06%
berubicin potential enroll
Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2021-05-19 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 13.45% H: 9.49% C: 9.11%
treatment fda friedreich's ataxia friedreich’s ataxia
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.46 96.8% 28M twitter stocktwits trandingview |
Finance
EDBL | News | $6.94 84.57% 1.4M twitter stocktwits trandingview |

CZOO | $7.74 55.11% 2.7M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology
OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance
MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a
MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services
PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing
BTCM | $3.41 26.3% 230K twitter stocktwits trandingview |
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.